Official funding announcement — preliminary draft
Funder: National Institutes of Health
Opportunity number: PAR-25-096
Official listed status: posted
Closing information: 2026-11-17 (official deadline clock time and time zone must be checked in NOFO)
Award disclosure: Official federal synopsis lists an award ceiling of 200,000; applicant-level applicability requires full-NOFO review.
Applicant categories in federal synopsis: Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments); Public housing authorities/Indian housing authorities; Private institutions of higher education; Public and State controlled institutions of higher education; State governments; Special district governments; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Native American tribal governments (Federally recognized); For profit organizations other than small businesses; County governments; Small businesses
Federal synopsis
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.
Draft intake record. Eligibility, program terms, current amendments and applicant ceiling must be independently verified before publishing.